Golub Capital BDC, Inc. — Form 10-Q Summary
Period clarification: The request metadata says 2021 Q3, but the supplied filing is for the quarter ended June 30, 2022, with nine-month comparisons through June 30, 2022. The figures below summarize the filing provided. Dollar amounts are in millions unless stated otherwise.
Business context and reporting period
Golub Capital BDC is an externally managed business development company and regulated investment company focused primarily on one-stop and other senior secured loans to U.S. middle-market companies. Its portfolio also includes selective second-lien, subordinated-debt, and equity investments. The filing is unaudited and covers the fiscal third quarter and first nine months ended June 30, 2022.
Financial performance and key metrics
| Metric | Three months ended June 30, 2022 | Comparable 2021 period | Nine months ended June 30, 2022 | Comparable 2021 period |
|---|---|---|---|---|
| Investment income | $95.6 | $75.8 | $268.2 | $226.0 |
| Net investment income | $53.9 | $42.1 | $142.2 | $121.4 |
| Net increase in net assets from operations | $15.4 | $82.9 | $145.4 | $268.6 |
| Earnings per share | $0.09 | $0.49 | $0.85 | $1.60 |
| Distributions declared per share | $0.30 | $0.29 | $0.90 | $0.87 |
- Quarterly net investment income was about 56% of investment income, versus about 56% a year earlier; nine-month figures were about 53% versus 54%. These are simple ratios of reported amounts, not a company-reported margin measure.
- At June 30, total assets were $5,770.2, investments at fair value were $5,613.6, and net assets were $2,587.7. NAV was $15.14 per share, down from $15.19 at September 30, 2021.
- Gross debt was $3,154.7; debt net of issuance costs was $3,135.7. The filing reports GAAP debt-to-equity of 1.23x and asset coverage of 181.5%. Debt carrying value was $3,154.7 versus estimated fair value of $2,977.2.
- Cash and cash equivalents were $81.4; restricted cash and cash equivalents were $34.9. Including foreign currencies and restricted foreign currencies, cash-flow statement cash totaled $121.2.
- For the nine months, operating activities used $575.4 of cash, reflecting investment fundings of $1,678.5 and portfolio principal payments and sale proceeds of $955.2. Financing activities provided $452.5. Cash, currencies, and restricted cash decreased by $122.9.
- Portfolio fair value rose to $5.6 billion from $4.9 billion at September 30, 2021, and portfolio companies increased to 328 from 296. One-stop loans represented 84.1% of portfolio fair value; equity investments represented 5.0%.
Material changes versus comparable periods
- Quarterly investment income increased 26% year over year, while net investment income increased 28%. Growth reflected a larger earning portfolio and higher floating-rate income.
- Quarterly operating results fell to $15.4 from $82.9, mainly because of $40.6 of net unrealized depreciation on investments, compared with $35.2 of net unrealized appreciation a year earlier. Management attributed the current-quarter depreciation primarily to wider market credit spreads.
- Nine-month operating results declined to $145.4 from $268.6, largely due to a $157.2 adverse year-over-year swing in net change in unrealized investment appreciation and depreciation. Net investment income nevertheless increased by $20.8.
- Interest and other debt financing expense rose to $60.4 for the nine months from $46.4, while average debt outstanding increased to $2,860.4 from $2,138.9. The effective annualized average borrowing rate was 2.8% for the nine months and 3.0% for the quarter.
- Non-accrual loans had fair value of $60.3, up from $46.1 at September 30, 2021. Eight portfolio companies were on non-accrual, versus six at fiscal year-end; non-accrual investments were 1.1% of debt investments at fair value.
Outlook, risks, contingencies, and unusual items
- The filing provides no specific earnings or investment guidance. Management said it believed available assets and liquidity were sufficient to meet $268.6 of unfunded investment commitments, including $42.9 on undrawn revolvers, considering cash, borrowing availability, and expected repayments.
- The board declared a subsequent quarterly distribution of $0.30 per share, payable September 29, 2022 to holders of record September 2, 2022.
- Floating-rate assets may benefit from rising benchmark rates, but borrowing costs also rise. The filing’s sensitivity estimate indicates that a 100-basis-point increase in base rates would increase annualized net investment income by approximately $37.2, assuming the balance sheet remained constant and no mitigating actions.
- Management identifies inflation, higher rates, wider credit spreads, economic and political uncertainty, COVID-19 developments, and Russia-Ukraine-related volatility and supply-chain issues as risks to portfolio-company performance and investment values. Software was the largest industry concentration at 24.4% of portfolio fair value.
- Most investments are valued using Level 3 inputs and significant unobservable assumptions; management cautions that actual liquidation proceeds may differ materially from reported fair values. The filing also notes foreign-currency, counterparty, and LIBOR-transition risks. LIBOR-linked securitization debt may require amendment or refinancing before the relevant USD LIBOR settings cease after June 30, 2023.
- Unusual items included a $4.8 reversal of the GAAP capital-gains incentive-fee accrual in the quarter, driven by unrealized depreciation; this was not an incentive fee payable under the advisory agreement. The adviser also waived $1.9 of base management fees in the first half of fiscal 2022.
- The filing reports ordinary-course legal and regulatory proceedings and states that management does not believe their disposition will materially affect the consolidated financial statements. No material subsequent events other than the declared distribution were disclosed.
Important facts for investors to verify
- Confirm the intended reporting period: the supplied filing is Q3 2022, not Q3 2021.
- Review the deterioration in portfolio marks, the effect of wider credit spreads, and how Level 3 valuation assumptions affect NAV.
- Track non-accrual loans, recoveries, and the health of the eight affected portfolio companies.
- Assess leverage, borrowing availability, covenant and asset-coverage headroom, and the impact of rising financing costs.
- Compare recurring cash interest income with PIK income, fees, distributions, and the cash required to fund new commitments.
- Verify the sustainability of the $0.30 quarterly distribution against taxable income, net investment income, and liquidity.